Here are the 10-K annual reports from THC Therapeutics Inc (THCT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow THCT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full THCT filings page.
THC Therapeutics, Inc. reports another development-stage year with no revenues and a net loss of $811,562 for the year ended July 31, 2024. The company continues to focus on its patented dHydronator herb dryer for cannabis and other plants.
Liquidity is extremely tight, with only $35 in cash, total assets of $10,648, and a working capital deficit of about $3.7M. Accumulated deficit reached roughly $39.2M, and auditors and management highlight substantial doubt about the company’s ability to continue as a going concern without new financing.